A new Aenova: medical business plans growth

German healthcare group Aenova is seeking consent from existing lenders to take over pharmaceutical firm Haupt Pharma. The acquisition forms part of plans to expand Aenova’s market share, as laid out by the company's private equity owner, BC Partners.

  • By Olivier Holmey
  • 03 Sep 2013

“In addition to continued organic growth, we are also planning further acquisitions to broaden the company’s range and to additionally enhance its competitive position in the international markets,” Stefan Zuschke, a managing partner at BC Partners, said in August 2012 of Aenova’s expansion strategy.

The €260m takeover will ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Total Volume $m No. of Deals Share % by Volume
1 Bank of America Merrill Lynch (BAML) 7,026 25 11.95
2 Citi 6,449 21 10.96
3 BNP Paribas 5,093 18 8.66
4 Barclays 4,040 11 6.87
5 Lloyds Bank 3,615 14 6.15

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 Citi 108,190.43 309 12.88%
2 Bank of America Merrill Lynch 95,782.14 279 11.40%
3 Wells Fargo Securities 80,847.28 245 9.63%
4 JPMorgan 58,524.24 184 6.97%
5 Credit Suisse 43,977.05 134 5.24%